Pardeep Heir

Pardeep Heir

ID: 1b839952-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Guidance on inventor discovery and “invention story” evidence in Canadian patent actions: Federal Court rules in favour of patentee

Pharma in Brief · September 19, 2023

FCA upholds selection patent protecting apixaban and rejects that a second patented invention was obvious to try

Pharma in Brief · August 15, 2022

Federal Court finds 45-day limitation period does not apply to s 8.2 PM(NOC) related rights of action for unlisted patents

Pharma in Brief · March 2, 2021

Practice Areas

Health Care and Life Sciences

Jurisdictions